Reduction in TNF alpha and oxidative stress by liraglutide: Impact on ketamine-induced cognitive dysfunction and hyperlocomotion in rats
- 1 August 2021
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 278, 119523
Abstract
No abstract availableKeywords
Funding Information
- Ain Shams University
This publication has 66 references indexed in Scilit:
- Central effects of GLP-1: new opportunities for treatments of neurodegenerative diseasesJournal of Endocrinology, 2013
- The glucagon-like peptide 1 analogue Exendin-4 attenuates alcohol mediated behaviors in rodentsPsychoneuroendocrinology, 2013
- The Glucagon-Like Peptide 1 Analogue, Exendin-4, Attenuates the Rewarding Properties of Psychostimulant Drugs in MicePLOS ONE, 2013
- Crosstalk between metabolic and neuropsychiatric disordersF1000 Biology Reports, 2012
- Exendin-4 decreases amphetamine-induced locomotor activityPhysiology & Behavior, 2012
- Brain-Derived Neurotrophic Factor and Neuropsychiatric DisordersPharmacological Reviews, 2012
- Drugs developed to treat diabetes, liraglutide and lixisenatide, cross the blood brain barrier and enhance neurogenesisBMC Neuroscience, 2012
- The Diabetes Drug Liraglutide Prevents Degenerative Processes in a Mouse Model of Alzheimer's DiseaseThe Journal of Neuroscience, 2011
- Neuroinflammation, oxidative stress, and the pathogenesis of Parkinson’s diseaseClinical Neuroscience Research, 2006
- Morris water maze: procedures for assessing spatial and related forms of learning and memoryNature Protocols, 2006